Windlas Biotech IPO GMP Today, Windlas Biotech IPO Grey Market Premium Updates | Windlas Biotech IPO Listing Gain, Latest target, Opening gain
Windlas Biotech Ltd initial public offer (IPO) is set to open for subscription on Aug 04 and close on Aug 06, after it received capital market regulator Sebi’s go-ahead to raise Rs 401.54 crore through public issue.
Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
Check out Windlas Biotech IPO grey market premium, Kostak rates, and subject to sauda rates as of today.
Windlas Biotech IPO Details:
|Issuer||Windlas Biotech Ltd|
|Issue Type||Book Built Issue IPO|
|Issue Period||Issue Opens: Aug 04, 2021|
|Issue Closes: Aug 06, 2021|
|Price Brand||₹448 to ₹460 Per Share|
|Issue Size||₹401.54 Crores|
|Face Value||Rs.5 per Equity Share|
|Market Lot||30 Shares|
|Maximum Bid amount for Retail||Rs. 2 Lakhs|
|QIB||50% of the issue size|
|NIB||15% of the issue size|
|Retail Individual Bidders||35% of the issue size|
|Fresh Issue||₹ 165 Cr|
|Offer for Sale||₹ 236.54 Cr|
|Listing at||NSE & BSE|
|Apply With||Upstox Free DEMAT Account|
|Grey Market Price||Windlas Biotech IPO GMP Today|
|UPCOMING IPO 2021||UPCOMING DIVIDEND|
|UPCOMING BUYBACK||UPCOMING NCD 2021|
|Best Stocks to buy||Latest IPO Grey Market Premium|
UPCOMING IPO IN AUGUST 2021
IPO ALLOTMENT TIPS & TRICKS
Windlas Biotech IPO Review
|DEVYANI INTERNATIONAL IPO GMP||KRSNAA DIAGNOSTICS IPO GMP|
|Exxaro Tiles IPO GMP||CARTRADE IPO GMP|
|APTUS IPO GMP|
Windlas Biotech IPO GMP Rates day by day
Windlas Biotech IPO Grey market premium as on today
|Date||GMP (in INR)||Kostak (in INR)||Subject to Sauda|
|17 AUG 2021|
|16 AUG 2021|
|15 AUG 2021||90|
|14 AUG 2021||90|
|13 AUG 2021||90|
|12 AUG 2021||22|
|11 AUG 2021||70|
|10 AUG 2021||40|
|06 AUG 2021||50|
|05 AUG 2021||90|
|04 AUG 2021||90|
|03 AUG 2021||90|
|02 AUG 2021||91|
|01 AUG 2021||90|
|31 July 2021||80|
|30 July 2021||70|
|29 July 2021|
How to Apply for Windlas Biotech IPO :
If you’re a new investor Open DEMAT Account for free with Angel Broking and build wealth with the best stock choices. Join 1 million+ family of happy customers.
In case you have not been allotted or for any partial allotment of IPO shares, the blocked amount, if any, will be unblocked/released on or before UPI mandate expiry date. Please reach out to your bank in case funds are not unblocked/released post the mandate expiry date.
Windlas Biotech IPO Market Lot:
|Lot Size:||Minimum 30 Shares & Maximum 420 Shares|
Windlas Biotech IPO Allotment & Listing:
|Basis of Allotment:||AUG 11, 2021|
|Refunds:||AUG 12, 2021|
|Credit to Demat Account:||AUG 13, 2021|
|Listing Date:||AUG 17, 2021|
Check:- Windlas Biotech IPO Allotment Status
– IPO Grey Market Premium (IPO GMP) mention is valid for the specific date as mentioned in the header.
– We are not buying and selling IPO forms on IPO Grey Market.
– Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
– Do not subscribe for IPO by just seeing premium Price as it may change anytime before listing. Subscribe only considering Fundamental of the companies.
– This is only coverage of News related to Grey Market . We don’t deal in Grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
IPO GMP rates are provided as sourced from market intelligence. Please note these IPO GMP rates may be different depending on geographies and markets.
We don’t trade into grey market nor do we facilitate buying or selling of IPO forms.
What is Grey Market?
Grey Market is the term used to describe unregulated over-the-counter market for trading IPO applications and IPO shares before the stock is listed at a stock market. This is a way for dealers to support their customers who may want to exit before listing.
This is also a way to boost the listing price and support the issue before listing happens. There are two kinds of transactions that happen in thee IPO grey market:
- Trade of IPO shares at a grey market premium
- Trade of IPO application at a kostak.
What is Grey Market Premium?
GMP or Grey Market Premium is the premium at which equity shares from the IPO are being traded in the grey market.
This could either be a positive or negative – meaning the trading price in the grey market is either higher or lower than issue price respectively, based on demand and supply for the shares.
Typically, investors who do not want to take the risk of allocation not happening through IPO will buy shares in the gray market and hope to flip the shares on listing to make a good profit.
What is Kostak?
Kostak is the premium at which IPO application is being traded in the grey market. Applications are typically traded after the application window is closed but the allotment has not yet been finished.
It is rare for someone to trade IPO application post-allocation. This is a way for investors to increase their chance of shares being allotted as the allocation process treats each retail application equally. An example (indicative) for kostak is:
Windlas Biotech Limited
Issue Price: Rs 306 Per Equity Share (Maximum Bid price)
Lot Size: 45
Grey Market Premium: Rs 220 to Rs 230
Kostak (Rs 13770): Rs 680 to Rs 720
This means Windlas Biotech applications of Rs 14400 are being traded in IPO Grey Market at Rs 695 to Rs 720.
Despite the fact that this IPO’s Grey Market Premium is roughly 75% of the issue price, the ‘Kostak’ is just 5% of the application value.
As can be seen the Kostak is at a much lower %age than GMP. This indicates that the grey market expects the issue to be oversubscribed and expects on an average only one lot to be allocated per application.
Kostak rate is the amount an investor gets by selling his/her IPO application in grey market. This is the amount an investor stands to gain, irrespective of allotment status.
Subject to Sauda simply reflects the amount which an investor stands to get by selling his/her application for firm allotment. The key operative word here is firm allotment. In case of no allotment to the applicant, the sauda stands cancelled.
In case of ‘Subject to Sauda’ deal, while selling IPO application in the grey market, buyer and seller agree that deal is only valid if the seller will get the allotment. If the seller doesn’t get any shares in IPO process, the deal gets avoid.